About August Bioservices
August Bioservices is a company based in Nashville (United States) founded in 2017.. August Bioservices has raised $88.6 million across 3 funding rounds from investors including Oak HC/FT and Polaris Partners. The company has 86 employees as of December 31, 2021. August Bioservices offers products and services including cGMP Manufacturing, cGMP Laboratory Services, and Research and Development. August Bioservices operates in a competitive market with competitors including Exela Pharma, Gland Pharma, ApiJect, Vetter Pharma and INCOG BioPharma Services, among others.
- Headquarter Nashville, United States
- Employees 86 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$88.6 M (USD)
in 3 rounds
-
Latest Funding Round
$65 M (USD), Series B
Dec 01, 2022
-
Investors
Oak HC/FT
& 1 more
-
Employee Count
86
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of August Bioservices
August Bioservices offers a comprehensive portfolio of products and services, including cGMP Manufacturing, cGMP Laboratory Services, and Research and Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Handles sterile fill/finish for pharmaceuticals
Conducts analytical and extractables testing
Offers full programs for drug creation
Unlock access to complete
Funding Insights of August Bioservices
August Bioservices has successfully raised a total of $88.6M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $65 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $65.0M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2022 | Amount | Series B - August Bioservices | Valuation | Oak HC/FT | |
| May, 2021 | Amount | Series A - August Bioservices | Valuation | Polaris Partners , Oak HC/FT |
|
| Jul, 2020 | Amount | Seed - August Bioservices | Valuation | Oak HC/FT |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in August Bioservices
August Bioservices has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Oak HC/FT and Polaris Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in early-stage healthtech and fintech startups.
|
Founded Year | Domain | Location | |
|
US focused venture capital firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by August Bioservices
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - August Bioservices
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
August Bioservices Comparisons
Competitors of August Bioservices
August Bioservices operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exela Pharma, Gland Pharma, ApiJect, Vetter Pharma and INCOG BioPharma Services, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
|
|
| domain | founded_year | HQ Location |
Generic injectable drugs are manufactured across therapeutic segments.
|
|
| domain | founded_year | HQ Location |
Medicine injectors are manufactured by ApiJect for medical applications.
|
|
| domain | founded_year | HQ Location |
CDMO specializing in aseptically prefilled syringe systems, cartridges and vials.
|
|
| domain | founded_year | HQ Location |
Injectable drug products are manufactured by this biopharma CDMO.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on August Bioservices
Frequently Asked Questions about August Bioservices
When was August Bioservices founded?
August Bioservices was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is August Bioservices located?
August Bioservices is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
Who is the current CEO of August Bioservices?
Jenn Adams is the current CEO of August Bioservices.
Is August Bioservices a funded company?
August Bioservices is a funded company, having raised a total of $88.6M across 3 funding rounds to date.
How many employees does August Bioservices have?
As of Dec 31, 2021, the latest employee count at August Bioservices is 86.
What does August Bioservices do?
Provider of diversified research services for clinical solutions. The company provides services in the functional characterization development of assay and in-vitro services. Drug discovery, protein engineeringprotein therapeutics using cytokines, enzymes, fusion proteins, humanized monoclonal antibody, mAbs, and protein conjugates, and cell line development are provided. Formulation, process design, analytical method development solutions are available for pharma development. Labeling, kitting, and other support services are provided for clinical manufacturing.
Who are the top competitors of August Bioservices?
August Bioservices's top competitors include Exela Pharma, Gland Pharma and Luoxin Pharmaceutical Group.
What products or services does August Bioservices offer?
August Bioservices offers cGMP Manufacturing, cGMP Laboratory Services, and Research and Development.
Who are August Bioservices's investors?
August Bioservices has 2 investors. Key investors include Oak HC/FT, and Polaris Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.